Monash IVF Group

Monash IVF Group EBIT per Employee

The EBIT per Employee of Monash IVF Group (MVF.AX) as of Oct 10, 2026 is 38,506.52 AUD. In the previous year, EBIT per Employee was 80,841.71 AUD — a change of -52.37% (lower).

EBIT per Employee

38,506.52AUD

YoY

-52.37%

Last updated:

EBIT per Employee of Monash IVF Group is 2026 38,506.52 AUD. EBIT per Employee of Monash IVF Group was 2025 80,841.71 AUD. It decreases by -52.37% lower compared to the previous year.

The Monash IVF Group EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2019
60,972.07 AUD
Jan 1, 2020
31,532.59 AUD
Jan 1, 2021
71,977.65 AUD
Jan 1, 2022
57,553.07 AUD
Jan 1, 2023
61,672.25 AUD
Jan 1, 2024
-10,445.07 AUD
Jan 1, 2025
80,841.71 AUD
Jan 1, 2026
38,506.52 AUD
The Monash IVF Group EBIT per Employee history
YEAREBIT per EmployeeYoY
38,506.52AUD-52.37%
80,841.71AUD-873.97%
-10,445.07AUD-116.94%
61,672.25AUD+7.16%
57,553.07AUD-20.04%
71,977.65AUD+128.26%
31,532.59AUD-48.28%
60,972.07AUD-1.25%
61,746.74AUD-25.68%
83,078.21AUD-1.67%
84,487.90AUD+19.73%
70,567.97AUD+5.42%
66,942.27AUD—
Access this data via the Eulerpool API

Monash IVF Group Stock analysis

What does Monash IVF Group do? The Monash IVF Group Ltd is a company in Australia specializing in reproductive medicine. It was founded in 1970 by Professor Gab Kovacs, who is considered one of the pioneers in the field of in-vitro fertilization (IVF). The company's history began in a small laboratory in Melbourne, where the first successful IVF procedures were performed. Over time, Monash IVF grew and expanded its focus to include other reproductive treatments such as donor egg programs, sperm donation, and cryopreservation. Monash IVF Group Ltd has since become a leading provider in Australia, with 19 clinics throughout the country. The company is not only active in Australia but also operates clinics in Malaysia and Vietnam. The business model of Monash IVF Group Ltd is centered around helping couples and individuals fulfill their desire to have children. The company offers a wide range of treatments tailored to the individual needs and circumstances of each patient. Among the services offered are not only IVF, donor egg programs, and sperm donation but also other technologies such as intracytoplasmic sperm injection (ICSI) and preimplantation genetic diagnosis (PGD). Monash IVF Group Ltd sees itself as an all-rounder and therefore also offers psychological support and guidance during and after treatments. One of the company's specialties is its comprehensive research work. The Monash IVF Group has a specialized research department actively involved in researching new reproductive technologies. The company collaborates closely with universities and leading scientific institutes to gain the latest insights in this field and achieve the best possible outcomes for its patients. Monash IVF Group Ltd is divided into various divisions, each with different focuses and offerings. The main division is the Monash IVF Clinic, specializing in reproductive health and fertility. Here, all common IVF and fertility treatments are offered. Another division is Monash IVF Fertility Diagnostics, specializing in diagnostics and screening of fertility and reproductive problems. State-of-the-art diagnostic procedures for evaluating male and female fertility are used here. Monash IVF Genomics is another division offering genetic counseling, screening, and diagnostics. Here, couples can determine their genetic risk factors for fertility problems and receive support in making the best possible decisions regarding family planning. In addition to these divisions, Monash IVF Group Ltd also offers specialized services. For example, there is the Monash IVF Donor Program, specializing in the facilitation of anonymous and open donor programs. The Monash IVF DNA Matching can also assist in the search for genetic relatives by utilizing advanced DNA profiling. As a leading company in the field of fertility, Monash IVF Group Ltd offers a wide range of products and services to help couples and individuals fulfill their desire to have children. With a long history of innovation and research, as well as a variety of divisions and offerings, the company is an important provider of reproductive medicine in Australia and beyond. Monash IVF Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Monash IVF Group stock

EBIT per Employee of Monash IVF Group is 38,506.52 AUD in 2026.

EBIT per Employee of Monash IVF Group changed from 80,841.71 AUD to 38,506.52 AUD, representing a -52.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Monash IVF Group since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Monash IVF Group historically and in real time.

Access this data via the Eulerpool API

Workforce — Monash IVF Group

All Key Metrics — Monash IVF Group